| Keywords: |
treatment outcome; overall survival; clinical trial; intensity modulated radiation therapy; dose response; patient selection; skin toxicity; treatment planning; note; adjuvant therapy; cancer patient; cancer radiotherapy; disease free survival; radiation dose; radiotherapy, adjuvant; cancer staging; neoplasm staging; quality of life; pain; breast cancer; breast; mastectomy; risk factors; editorial; pathology; dose-response relationship, drug; breast neoplasms; risk factor; time; time factors; risk assessment; radiation dosage; prostate cancer; health care quality; standard; head and neck cancer; radiotherapy, intensity-modulated; dosimetry; breast tumor; partial mastectomy; radiation beam; pain measurement; pain assessment; radiation field; quality of health care; radiation dermatitis; segmental mastectomy; mastectomy, segmental; acute disease; desquamation; radiodermatitis
|
